Wilfred van Zuilen
Corporate Officer/Principal chez ZIMMER BIOMET HOLDINGS, INC.
Fortune : 945 901 $ au 31/03/2024
Profil
Wilfred van Zuilen is currently the Group President-EMEA at Zimmer Biomet Holdings, Inc. He previously worked as the Regional Vice President-North Western Europe at Medtronic, Inc. He completed his undergraduate degree at Erasmus University Rotterdam.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 06/03/2024 | 7 167 ( 0,00% ) | 945 901 $ | 31/03/2024 |
Postes actifs de Wilfred van Zuilen
| Sociétés | Poste | Début |
|---|---|---|
| ZIMMER BIOMET HOLDINGS, INC. | Corporate Officer/Principal | 07/06/2021 |
Anciens postes connus de Wilfred van Zuilen
| Sociétés | Poste | Fin |
|---|---|---|
Medtronic, Inc.
 Medtronic, Inc. Medical SpecialtiesHealth Technology Medtronic, Inc. operates as a medical technology company. It offers implantable cardiac pacemakers, eternal defibrillators, inferior turbinate surgery products, and continuous glucose monitoring device. The company was founded by Earl E. Bakken and Palmer J. Hermundslie on April 29, 1949 and is headquartered in Minneapolis, MN. | Corporate Officer/Principal | - |
Formation de Wilfred van Zuilen
| Erasmus University Rotterdam | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ZIMMER BIOMET HOLDINGS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Medtronic, Inc.
Medtronic, Inc. Medical SpecialtiesHealth Technology Medtronic, Inc. operates as a medical technology company. It offers implantable cardiac pacemakers, eternal defibrillators, inferior turbinate surgery products, and continuous glucose monitoring device. The company was founded by Earl E. Bakken and Palmer J. Hermundslie on April 29, 1949 and is headquartered in Minneapolis, MN. | Health Technology |
